Recent trends and development in antiviral chemotherapy.
E
E
De Clercq
D000212:Acyclovir / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D000998:Antiviral Agents / Q000494:pharmacology / Q000627:therapeutic use*; D055598:Chemical Phenomena; D002621:Chemistry; D004279:DNA, Viral / Q000096:biosynthesis; D015774:Ganciclovir; D006566:Herpesviridae Infections / Q000188:drug therapy; D006801:Humans; D007372:Interferons / Q000494:pharmacology / Q000627:therapeutic use; D010766:Phosphorylation; D010850:Picornaviridae Infections / Q000188:drug therapy; D012192:Retroviridae Infections / Q000188:drug therapy; D012254:Ribavirin / Q000494:pharmacology / Q000627:therapeutic use; D012435:S-Adenosylhomocysteine / Q000378:metabolism; D013498:Suramin / Q000494:pharmacology / Q000627:therapeutic use; D014777:Virus Diseases / Q000188:drug therapy*; D014779:Virus Replication / Q000187:drug effects
D000998:Antiviral Agents; D004279:DNA, Viral; D012254:Ribavirin; D013498:Suramin; D007372:Interferons; D012435:S-Adenosylhomocysteine; D015774:Ganciclovir; D000212:Acyclovir